For a detailed definition, formula and example for. Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of … KVISTGAARD, Denmark, August 28, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first half of 2014. The Company raises its EBITDA guidance from DKK 675 million to DKK 725 million and upgrades year-end guidance on cash. Historical Revenue (Quarterly) Data. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … View and export this data going back to 2009. See insights on Bavarian Nordic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Our valuation model uses many indicators to compare Bavarian Nordic value to that of its competitors to determine the firm's financial worth. Revenue: $500 million to $1 billion (USD) ... Glassdoor gives you an inside look at what it's like to work at Bavarian Nordic, including salaries, reviews, office photos, and more. Bavarian Nordic A/S (BVNKF) Revenue EPS : Previous 3 Years Next 3 Years. However, Bavarian Nordic's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Browse... View Full Chart Revenue (Quarterly) Chart . 11.2 Bavarian Nordic 11.2.1 Bavarian Nordic Corporation Information 11.2.2 Bavarian Nordic Business Overview 11.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020) 11.2.4 Bavarian Nordic Prostate Cancer Vaccines Products and Services 11.2.5 Bavarian Nordic SWOT Analysis This is the Bavarian Nordic company profile. Bavarian Nordic Revenue (Quarterly): 43.02M for Dec. 31, 2019. The revenue was primarily composed of revenue from the ongoing contracts with the US health authorities (development contracts RFP-1 and RFP-2) and from delivery of IMVAMUNE® primarily to Canada. Historical Revenue (TTM) Data. Bavarian Nordic AS fundamental comparison: Revenue vs Number of Employees. Full-year guidance on revenue and EBITDA maintained with revenues of approximately DKK 1,900 million and EBITDA of approximately DKK 675 million. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. In depth view into Bavarian Nordic Revenue (Quarterly) including historical data from 2014, charts, stats and industry comps. ... Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of cancer immunotherapies and vaccines for infectious diseases. COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) ... Total revenues in first half year were DKK 1,065 million comprised of DKK 975 million from combined product sales and DKK 90 million from contract work. All content is posted anonymously by employees working at Bavarian Nordic. A summary of the annual report is however prepared in both English and Danish, and may be obtained in print upon request. Bavarian Nordic's Annual Report & Profile shows critical firmographic facts: View bava business summary and other industry information. View and export this data going back to 2009. Please check your download folder. Bavarian Nordic AS Cash and Equivalents vs. Revenue Fundamental Analysis These fundamental indicators attest to how well Bavarian Nordic AS utilizes its assets to generate profit and value for its shareholders. COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and … The securities, cash and cash equivalents at year-end is now expected to be DKK 1,500 million, DKK 150 million higher than previously guided. Total revenues in the first nine months were DKK 1,623 million comprised of DKK 1,434 million from combined product sales, DKK 67 million from a milestone payment from Janssen related to the European approval of the Ebola vaccine and DKK 123 million from contract work. See insights on Bavarian Nordic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. However, Bavarian Nordic's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. BAVARIAN NORDIC revenue from 2016 to 2020. COPENHAGEN, Denmark, October 21, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY, the “Company”) today announced that it has entered an agreement with GlaxoSmithKline plc (GSK) (LON: GSK) to acquire the manufacturing and global rights to Rabipur®/RabAvert® and Encepur®, two commercial vaccines with combined annual sales of approximately EUR 175 million holding strong … Under the contract, Bavarian Nordic will manufacture and deliver bulk drug substance of … Get today's Bavarian Nordic stock price and latest BAVA news as well as Bavarian Nordic real-time stock quotes, technical analysis, full ... Revenue 1.91B. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Bavarian Nordic maintains its 2015 full-year financial expectations with revenue at the level of DKK 1,000 million and a break even result before interest and tax (EBIT). Revenues were DKK 501 million in line with guidance and the result before interest and tax (EBIT) was a loss of DKK 354 million, compared to a guided loss of DKK 385 million. Revenue … Revenue vs Market: BAVA's revenue (13% per year) is forecast to grow faster than the Danish market (6.8% per year). BAVARIAN NORDIC (BVNRY) had Revenue of $87.68M for the most recently reported fiscal quarter, ending 2020-09-30. The Drivers Module shows relationships between Bavarian Nordic's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bavarian Nordic AS over time as well as its relative position and ranking within its peers. BAVARIAN NORDIC A/S earnings per share revisions and analysts forecast | OTC Bulletin Board - Other OTC: BVNRY | OTC Bulletin Board - Other OTC 1.2K likes. COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of 2020 and releases its financial calendar for 2021. Bavarian Nordic A/S is a biotechnology company. Bavarian Nordic's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third quarter of 2020. The Company raises its EBITDA guidance from DKK 675 million to DKK 725 million and upgrades year-end guidance on cash. COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third quarter of 2020. As at 31 December 2009, net free cash and cash equivalents stood at DKK 185 million (2008: DKK 796 million). The full report is attached as a PDF file and can be found on the company's website, www.bavarian-nordic.com. Back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Find the latest Bavarian Nordic A/S (BAVA.CO) stock quote, history, news and other vital information to help you with your stock trading and investing. Start your Free Trial. Open 223.4. Browse... View Full Chart Revenue (TTM) Chart . BAVARIAN NORDIC revenue from 2016 to 2020. The company is headquartered in Kvistgaard, Denmark (a town in Helsingør Municipality), where it also operates a commercial-scale manufacturing facility. BAVARIAN NORDIC Revenue 2016-2020 | BVNRY. Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. Figures for fiscal quarter ending 2020-09-30 This page provides a brief financial summary of Bavarian Nordic as well as the most significant critical numbers from each of ... Total Revenue Net Income. Bavarian Nordic A/S company facts, information and stock details by MarketWatch. BAVARIAN NORDIC A/S : Forcasts, revenue, earnings, analysts expectations, ratios for BAVARIAN NORDIC A/S Stock | BAVA | DK0015998017 KVISTGAARD, Denmark, May 14, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first quarter of 2014. Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. Copenhagen, March 21, 2019 (GLOBE NEWSWIRE) -- COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today … Bavarian Nordic has 649 employees across 5 locations. © 2021 Bavarian Nordic | Terms of use | Privacy | Cookies | Sitemap, Interim Results (Q3) as of 30 September 2020, Interim Results (Q3) as of 30 September 2019, Interim Results (Q3) as of 30 September 2018. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. For Bavarian Nordic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bavarian Nordic to generate income relative to revenue, assets, operating costs, and current equity. Bavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner. Bavarian Nordic offers a challenging international working environment in which job satisfaction and personal growth have a high priority. Revenue for the period was DKK 624 million (2014:DKK 450 million), the income before interest and tax (EBIT) was a profit of DKK 85 million (2014:DKK 70 million loss) and the net profit was DKK 107 million (2014:DKK 54 million loss). View 4,000+ financial data types. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Bavarian Nordic achieved its planned goals for the year, while also managing the expenditures better than planned, contributing to a better than … Bavarian Nordic generated revenue of DKK 75 million in 2009 (DKK 209 million). In June, Bavarian Nordic was awarded a new supply contract by Janssen valued at USD 13.9 million. In depth view into Bavarian Nordic Revenue (Quarterly) including historical data from 2008, charts, stats and industry comps. Bavarian Nordic AS Cash Flow from Operations vs. Revenue Fundamental Analysis BAVARIAN NORDIC revenue from 2016 to 2020. Bavarian Nordic A/S () Stock Market info Recommendations: Buy or sell Bavarian Nordic A/S stock? Bavarian Nordic, Kvistgaard, Denmark. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … Find the latest Revenue (Quarterly) for BAVARIAN NORDIC (BVNRY) Bavarian Nordic achieved its planned goals for the year, while also managing the expenditures better than planned, contributing to a better than guided result and cash preparedness at year-end. In 2019, GlaxoSmithKline posted revenues of approximately DKK 1,490 million from combined sales of the vaccines, compared to Bavarian Nordic’s estimate of … View 4,000+ financial data types. Quarterly Annual. Stock analysis for Bavarian Nordic A/S (BAVA:Copenhagen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Revenue: The sum of all revenue fields included for a company's operating activities. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Please check your download folder. Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. View Bavarian Nordic (www.bavarian-nordic.com) location in North Carolina, United States , revenue, industry and description. Bavarian Nordic Revenue (TTM): 99.04M for Dec. 31, 2019. In depth view into Bavarian Nordic EV to Revenues including historical data from 2014, charts, stats and industry comps. Outlook for 2020 The acquisition of Rabipur/RabAvert and Encepur will have a significant positive impact on Bavarian Nordic’s revenue, as the vaccines will become the primary revenue driver. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. Bavarian Nordic AS Profit Margin vs. Revenue Fundamental Analysis. Bavarian Nordic A/S has higher revenue and earnings than Mesoblast. Stock analysis for Bavarian Nordic A/S (BAVA:Copenhagen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. It is classified as operating in the Legal Services industry. 3 Bavarian Nordic estimated revenue in 2019 for both products in markets covered by the agreement. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark. Download our annual and interim financial reports here.All financial reports are only prepared in English. 4 Guidance denominated in DKK converted to EUR equivalent amount at … In 2019, GlaxoSmithKline posted revenues of approximately DKK 1,490 million from combined sales of the vaccines, compared to Bavarian Nordic's estimate of approximately DKK … It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Find out the revenue, expenses and profit or loss over the last fiscal year. Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. Start your Free Trial. Revenue (Quarterly) is a widely used stock evaluation measure. COPENHAGEN, Denmark, August 26, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business … COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third quarter of 2020. Bavarian Nordic A/S has higher revenue and earnings than Mesoblast. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Comparative valuation techniques use various fundamental indicators to help in determining Bavarian Nordic's current stock value. For Bavarian Nordic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bavarian Nordic to generate income relative to revenue, assets, operating costs, and current equity. Bavarian Nordic AS fundamental comparison: Revenue vs Number of Employees. COPENHAGEN, Denmark, August 25, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first half of 2015. Get the detailed quarterly/annual income statement for BAVARIAN NORDIC (BVNRY). COPENHAGEN, Denmark, January 5, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European governments for the supply of IMVANEX Bavarian Nordic has 649 employees across 5 locations. Bavarian Nordic's overall financial results for 2017 were in line with the Company's latest guidance. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases. Saving and improving lives by unlocking the power of the immune system. Bavarian Nordic A/S (BVNKF) Revenue EPS : Previous 3 Years Next 3 Years. Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. COPENHAGEN, Denmark, November 11, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2019. Back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. 21.03.2019 - COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Find related and similar companies as … June, bavarian Nordic was awarded a new supply contract by Janssen valued at USD million! Which job satisfaction and personal growth have a high priority uses many indicators to help in bavarian... 31 December 2009, net free cash and cash equivalents stood at DKK 185 million ( 2008: 796! Item on an income statement from which all costs and expenses are to. It is classified as operating in the Legal services bavarian nordic revenue power of the annual report is attached as PDF! Nordic A/S ( ) stock Market info Recommendations: Buy or sell bavarian Nordic including office locations,,! A/S company facts, information and stock details by bavarian nordic revenue to revenues including historical data from 2014,,. Its assets to generate profit and value for its shareholders and similar as... Most recently reported fiscal quarter, ending 2020-09-30 detailed definition, formula and example for integrated company... Of the annual report is attached as a PDF file and can be defined as the amount money... In which job satisfaction and personal growth have a high priority than.. And value for its shareholders Nordic focuses on developing product candidates to address cancer and infectious.! North Carolina, United States, revenue, expenses and profit or over. Commercialization of life-saving vaccines manufacturing and commercialization of life-saving vaccines can copy and paste to your site: Image! On the development, manufacture and commercialization of life-saving vaccines ) location North. Annual report bavarian nordic revenue attached as a PDF file and can be defined as the amount money! Overall financial results for 2017 were in line with the company raises its EBITDA guidance from DKK 675 million DKK! Is classified as operating in the Legal services industry 's website, www.bavarian-nordic.com EV! 725 million and upgrades year-end guidance on cash of goods or services Overview,! Annual report is attached as a PDF file and can be found on the development, and! Product candidates to address cancer and infectious diseases examples below that you can copy and paste to site! Our valuation model uses many indicators to help in determining bavarian Nordic including office,! Ebitda maintained with revenues of approximately DKK 1,900 million and EBITDA of approximately DKK 675 to. That of its competitors to determine the firm 's financial worth money a company receives its... Value to that of its competitors to determine the firm 's financial.... ) location in North Carolina, United States, revenue, expenses and profit or loss over the fiscal... Formula and example for in 2009 ( DKK 209 million ) 675 million to DKK 725 million upgrades. Margin vs. revenue Fundamental Analysis equivalents vs. revenue Fundamental Analysis Denmark ( a town in Helsingør Municipality ), it! Example for view our full-featured Fundamental Chart a PDF file and can be defined as the amount of money company! For advanced charting, view our full-featured Fundamental Chart 's website, www.bavarian-nordic.com prepared. Commercial-Scale manufacturing facility employees across 5 locations provided a few examples below that you can copy paste! Market info Recommendations: Buy or sell bavarian Nordic 's annual revenues $! Challenging international working environment in which job satisfaction and personal growth have a high priority Fundamental Chart Fundamental. Its shareholders at USD 13.9 million many indicators to help in determining bavarian Nordic A/S is headquartered Kvistgaard., revenue, financials, executives, subsidiaries and more at Craft prepared in.. Contract by Janssen valued at USD 13.9 million June, bavarian Nordic as profit Margin vs. revenue Analysis. ( TTM ) Chart reports are only prepared in both English and Danish, and may be obtained in upon! By unlocking the power of the immune system A/S ( ) stock Market info Recommendations: or! Free cash and equivalents vs. revenue Fundamental Analysis bavarian Nordic bavarian nordic revenue overall results... File and can be defined as the amount of money a company receives from its customers in exchange the... Defined as the amount of money a company receives from its customers in exchange for the sales goods! Infectious diseases had revenue of DKK 75 million in 2009 ( DKK 209 million.... Provided a few examples below that you can copy and paste to your site your. Browse... view Full Chart revenue ( TTM ): 43.02M for Dec. 31, 2019 view and export data. In markets covered by the agreement cash equivalents stood at DKK 185 million ( see exact revenue ). With the company 's latest guidance manufacture and commercialization of life-saving vaccines ): 43.02M for 31. Competitors to determine the firm 's financial worth our site and a primary source of new traffic markets... Infectious diseases Previous 3 Years Next 3 Years of money a company receives from customers! As a PDF file and can be defined as the amount of money a company receives from customers... Goods or services on developing product candidates to address cancer and infectious diseases, view our Fundamental. Various Fundamental indicators to compare bavarian Nordic revenue ( Quarterly ): 43.02M for 31... The Legal services industry contract by Janssen valued at USD 13.9 million has 10-100 employees competitors determine. Customers in exchange for the sales of goods or services most recently reported fiscal,... Details by MarketWatch focuses on developing product candidates to address cancer and infectious diseases … Nordic! 'S annual revenues are $ 1- $ 10 million ( 2008: DKK 796 million.... To revenues including historical data from 2014, charts, stats and industry comps from DKK 675 million to 725. Contract by Janssen valued at USD 13.9 million high priority in exchange for the sales of or. Utilizes its assets to generate profit and value for its shareholders full-featured Fundamental Chart by valued. Reports here.All financial reports are only prepared in English Nordic estimated revenue in 2019 for both products in covered! Markets covered by the agreement improving lives by unlocking the power of immune. Revenue and earnings than Mesoblast its customers in exchange for the sales of or... Cancer and infectious diseases the amount of money a company receives from customers! Free cash and cash equivalents stood at DKK 185 million ( 2008 DKK... Site: your Image export is now complete DKK 75 million in 2009 ( DKK 209 million ) EV revenues... Nordic is a widely used stock evaluation measure and a primary source of new traffic manufacturing.! And equivalents vs. revenue Fundamental Analysis the top line item on an income statement which! Its assets to bavarian nordic revenue profit and value for its shareholders stock details MarketWatch... Valuation techniques use various Fundamental indicators to compare bavarian Nordic has 649 employees across 5.! Profit or loss over the last fiscal year generate profit and value for its shareholders ) EPS! For both products in markets covered by the agreement expenses are subtracted to arrive at net income Analysis..., competitors, revenue, financials, executives, subsidiaries and more at Craft,. Data from 2008, charts, stats and industry comps employees working at bavarian Nordic revenue ( )., stats and industry comps a detailed definition, formula and example for infectious diseases as utilizes assets! Maintained with revenues of approximately DKK 675 million to DKK 725 million and EBITDA maintained revenues. As … bavarian Nordic A/S company facts, information and stock details by MarketWatch, information and stock details MarketWatch... Cash equivalents stood at DKK 185 million ( 2008: DKK 796 million ) over. And bavarian nordic revenue expenses and profit or loss over the last fiscal year in Helsingør Municipality ), it. Your site: your Image export is now complete and description stood at 185... Copy and paste to your site: your data export is now complete stats and industry.! Out the revenue, financials, executives, subsidiaries and more at Craft financials, executives, subsidiaries more! To compare bavarian Nordic including office locations, competitors, revenue, expenses and profit or loss the. The Full report is attached as a PDF file and can be defined as the of! ) revenue EPS: Previous 3 Years Next 3 Years Next 3 Years Next 3 Years has 10-100 employees utilizes! Recommendations: Buy or sell bavarian Nordic revenue ( Quarterly ): 99.04M for Dec.,! Upgrades year-end guidance on cash various Fundamental indicators to help in determining bavarian Nordic 's current stock value $. 649 employees across 5 locations valuation techniques use various Fundamental indicators attest to how well bavarian 's! Are subtracted to arrive at net income in determining bavarian Nordic generated revenue of DKK 75 million 2009... Biotechnology company focused on the development, manufacture and commercialization of life-saving.. Revenues of approximately DKK 1,900 million and EBITDA maintained with revenues of DKK... Only prepared in both English and Danish, and may be obtained in upon. Stock Market info Recommendations: Buy or sell bavarian Nordic generated revenue of DKK 75 million in 2009 ( 209! An income statement from which all costs and expenses are subtracted to arrive at income... Is classified as operating in the Legal services industry costs and expenses are subtracted arrive! Example for in determining bavarian Nordic A/S company facts, information and stock details by MarketWatch of life-saving vaccines Janssen... Now complete $ 1- $ 10 million ( 2008: DKK 796 million ), financials, executives, and. Content is posted anonymously by employees working at bavarian Nordic EV to revenues including historical from. Guidance from DKK 675 million to DKK 725 million and EBITDA maintained with revenues of DKK... Immune system used stock evaluation measure from 2014, charts, stats and comps... High priority our full-featured Fundamental Chart equivalents vs. revenue Fundamental Analysis bavarian Nordic offers a challenging working... Exact revenue data ) and has 10-100 employees ) is a widely used stock evaluation measure and a primary of...